Spectrascience Net Income Per Share vs Capex To Revenue Analysis
Spectrascience New financial indicator trend analysis is much more than just breaking down Spectrascience New prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Spectrascience New is a good investment. Please check the relationship between Spectrascience New Net Income Per Share and its Capex To Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.
Net Income Per Share vs Capex To Revenue
Net Income Per Share vs Capex To Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Spectrascience New Net Income Per Share account and Capex To Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Spectrascience New's Net Income Per Share and Capex To Revenue is -0.31. Overlapping area represents the amount of variation of Net Income Per Share that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Spectrascience New, assuming nothing else is changed. The correlation between historical values of Spectrascience New's Net Income Per Share and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income Per Share of Spectrascience New are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Net Income Per Share i.e., Spectrascience New's Net Income Per Share and Capex To Revenue go up and down completely randomly.
Correlation Coefficient | -0.31 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Net Income Per Share
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most indicators from Spectrascience New's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Spectrascience New current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.The current year's Sales General And Administrative To Revenue is expected to grow to 228.44, whereas Selling General Administrative is forecasted to decline to about 1.4 M.
Spectrascience New fundamental ratios Correlations
Click cells to compare fundamentals
Spectrascience New Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Spectrascience New is a strong investment it is important to analyze Spectrascience New's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Spectrascience New's future performance. For an informed investment choice regarding Spectrascience Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (0.92) |
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.